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Carboxypeptidase Z (CPZ) Links Thyroid Hormone and Wnt Signaling
Pathways in Growth Plate Chondrocytes
Lai Wang, Yvonne Y Shao, and R Tracy Ballock
ABSTRACT: Carboxypeptidase Z (CPZ) removes carboxyl-terminal basic amino acid residues, particularly
arginine residues, from proteins. CPZ contains a cysteine-rich domain (CRD) similar to the CRD found in
the frizzled family of Wnt receptors. We have previously shown that thyroid hormone regulates terminal
differentiation of growth plate chondrocytes through activation of Wnt-4 expression and Wnt/b-catenin
signaling. The Wnt-4 protein contains a C-terminal arginine residue and binds to CPZ through the CRD. The
objective of this study was to determine whether CPZ modulates Wnt/b-catenin signaling and terminal
differentiation of growth plate chondrocytes. Our results show that CPZ and Wnt-4 mRNA are co-expressed
throughout growth plate cartilage. In primary pellet cultures of rat growth plate chondrocytes, thyroid
hormone increases both Wnt-4 and CPZ expression, as well as CPZ enzymatic activity. Knockdown of either
Wnt-4 or CPZ mRNA levels using an RNA interference technique or blocking CPZ enzymatic activity with
the carboxypeptidase inhibitor GEMSA reduces the thyroid hormone effect on both alkaline phosphatase
activity and Col10a1 mRNA expression. Adenoviral overexpression of CPZ activates Wnt/b-catenin sig-
naling and promotes the terminal differentiation of growth plate cells. Overexpression of CPZ in growth
plate chondrocytes also removes the C-terminal arginine residue from a synthetic peptide consisting of the
carboxyl-terminal 16 amino acids of the Wnt-4 protein. Removal of the C-terminal arginine residue of Wnt-4
by site-directed mutagenesis enhances the positive effect of Wnt-4 on terminal differentiation. These data
indicate that thyroid hormone may regulate terminal differentiation of growth plate chondrocytes in part by
modulating Wnt signaling pathways through the induction of CPZ and subsequent CPZ-enhanced activation
of Wnt-4.
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INTRODUCTION
C
ARBOXYPEPTIDASES ARE ZINC-CONTAINING exopeptidases
that catalyze the removal of C-terminal amino acids
from proteins and peptides. The members of the N/E
subfamily of carboxypeptidases are selective enzymes re-
lying on their substrate speciﬁcity and are thought to play
a role in the processing of intercellular peptide messen-
gers.
(1) A well-studied N/E enzyme is carboxypeptidase N
(CPN). CPN inactivates bradykinin and kallidin II by re-
moval of their C-terminal arginine residues.
(2) CPN also
removes the C-terminal arginine from anaphylatoxin C3a,
C4a, and C5a, which reduces their biological activities
(3)
and is responsible for the signiﬁcant reduction in biological
activity of chemokine SDF-1a that occurs through removal
of its C-terminal lysine.
(4)
Carboxypeptidase Z (CPZ) belongs to the N/E sub-
family of carboxypeptidases. CPZ functions at neutral pH
to remove basic amino acids, particularly arginine residues,
from the carboxyl terminus of proteins.
(1,5) CPZ contains a
cysteine-rich domain (CRD) with 20–30% homology to the
CRD present in the frizzled family of Wnt receptors, sug-
gesting that CPZ may function as a modulator of Wnt
signaling. A genomic analysis showed upregulation of CPZ
expression along with activation of Wnt/b-catenin signal-
ing during the alachlor-induced oncogenesis that occurs in
rat olfactory mucosa.
(6) The expression of CPZ also over-
laps with the expression pattern of several Wnt genes and
persists in cartilage condensations throughout mouse ges-
tation.
(7) Moeller et al.
(8) showed expression of CPZ in the
somites and sclerotome of the developing chicken embryo.
Overexpression of CPZ in the chick somite induced the
expression of the Wnt-responsive gene, Pax3, and resulted
in dysmorphogesis of the scapula and ribs.
Wnt signaling has recently been recognized as an impor-
tant signal transduction pathway in regulating chondrocyte
proliferation and differentiation during limb development.
The role of thyroid hormone in the regulation of skeletal
development, particularly in the transition to the terminally
differentiated growth plate chondrocyte, occurs in part
through the modulation of canonical Wnt signaling.
(9)
Thyroid hormone may therefore exert its potent effect on
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265maturation of the growth plate through activation of Wnt-4
expression and Wnt/b-catenin signaling.
Wnt proteins are locally released from cells and diffuse
into the extracellular space. CPZ protein is also secreted
and located in the extracellular matrix, suggesting that
CPZ could directly interact with Wnt proteins. Given that
Wnt-4 contains a C-terminal arginine, that CPZ binds to
Wnt-4 through its CRD, and that CPZ enhances the Wnt-
4–dependent induction of the homeobox gene Cdx1,
(8) it is
reasonable to postulate that CPZ may enhance Wnt-4 ac-
tivity through enzymatic removal of its terminal arginine.
The objective of this study therefore was to determine
whether CPZ modulates Wnt/b-catenin signaling and ter-
minal differentiation of growth plate chondrocytes.
MATERIALS AND METHODS
Cell culture
Chondrocytes were isolated from the distal femoral
growth plate of 2-day-old neonatal Sprague-Dawley rats by
sequential digestion in trypsin/EDTA (Invitrogen, Carls-
bad, CA, USA) for 1 h at 378C, followed by 0.3% colla-
genase type I (Worthington, Lakewood, NJ, USA) for 4 h
at 378C.
(10) Cells were resuspended in DMEM/F12 medium
(Invitrogen) supplemented with a deﬁned media supple-
ment (ITS+1; Sigma, St Louis, MO, USA) and plated in
monolayer at a density of 2 3 10
5 cells/cm
2 or in 3D pellet
culture at 2 3 10
5 cells per 15-ml conical tube.
(9) Triiodo-
thyronine (T3; Sigma) was added to the medium at a
concentration of 100 ng/ml. 2-guanidinoethylmercapto-
succinic acid (GEMSA; Calbiochem, La Jolla, CA, USA)
was used as an inhibitor of carboxypeptidase activity.
An adenovirus was constructed (Vectorlab, Philadelphia,
PA, USA) using a plasmid consisting of a long form of
human CPZ cDNA containing the CRD, the carboxypep-
tidase domain, and a His-6 tag
(11) (kindly supplied by Dr
LD Fricker, Albert Einstein College of Medicine, Bronx,
NY, USA). A similar adenovirus containing the CMV
promoter was used as a negative control. Growth plate
chondrocytes were plated in 60-mm dishes and infected
with adenoviral vectors with a MOI (multiplicity of infec-
tion) of 100. The efﬁciency of the Ad-CPZ infection was
conﬁrmed by immunoblotting with anti-His-6 antibody.
Twenty-four hours after infection, the cells in monolayer
were trypsinized and maintained as pellet cultures in the
presence or absence of T3.
Laser capture microdissection
Frozen sections (10 mm thick) of 2-day-old rat distal
femoral growth plate were cut on a cryostat, attached to
foil mounted frame slides (Leica, Wetzkar, Germany), and
stained with toluidine blue. Cell populations of resting
zone (RZ), proliferating zone (PZ), prehypertrophic zone
(preHZ), and hypertrophic zone (HZ) were collected using
laser capture microdissection (LCM; Leica).
Quantitative real-time PCR
Total RNA was isolated from cultured growth plate
chondrocytes using the RNeasy Kit (Qiagen, Valencia,
CA, USA) according to the manufacturer’s instructions.
Total RNA of microdissected growth plate cartilage was
extracted using the RNeasy Micro Kit (Qiagen). Reverse
transcription was performed using random primers and
Superscript III DNA polymerase (Invitrogen). Real-time
PCR reactions were conducted in an ABI Prism 7700
Sequence Detection System using SYBR Green PCR core
reagents (Applied Biosystems, Foster City, CA, USA).
The forward and reverse primers for the ampliﬁcations
were as follows: CPZ, 59-CCTTTGACGCCATCGACAT-
39 and 59-GAGGGTCATAGCAGCCTTCCT-39; Wnt-4,
59-AACCGGCGCTGGAACTG-39 and 59-GGTCCCTT
GTGTCACCACCTT-39; Col10a1, 59-GATCATGGAGC
TCACGGAAAA-39 and 59-CCGTTCGATTCCGCATT
G-39; 18s, 59-AGTCCCTGCCCTTTGTACACA-39 and
59-GATCCGAGGGCCTCACTAAAC-39.
Immunoblotting
Whole cell extracts were prepared from cultured chon-
drocytes using modiﬁed RIPA buffer (50 mM Tris-HCl, pH
7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl,
1 mM EDTA, 1 mM PMSF, 1 mg/ml of each aprotinin,
leupeptin, and pepstatin, 1 mM Na3VO4, 1 mM NaF). An
equal amount of protein was separated by 10% SDS-
PAGE and transferred onto nitrocellulose membranes.
CPZ protein was detected using rabbit polyclonal antisera
raised against the C-terminal 73 amino acids of rat CPZ (a
gift from Dr Lloyd Fricker).
(5) The cellular accumulation
of b-catenin was detected using an antibody against b-
catenin (Santa Cruz Biotechnology, Santa Cruz, CA,
USA). Anti-b-actin (Sigma) was used as an internal con-
trol. The blots were incubated with a horseradish peroxi-
dase (HRP)-conjugated secondary antibody (Santa Cruz).
Immunoreactive proteins were visualized by Western
blotting chemiluminescence luminol reagent (Santa Cruz).
For co-immunoprecipitation studies, cell lysates from
growth plate chondrocytes transfected with a Wnt-4 ex-
pression plasmid and infected with Ad-CPZ were incu-
bated with CPZ antisera for 2 h at 48C, followed by an
addition of protein A/G-agarose (Santa Cruz) for over-
night incubation on a rotating device. The precipitated
proteins were separated by SDS-PAGE and blotted onto
nitrocellulose membranes. Immunodetection was carried
out using an antibody against Wnt-4 (Zymed, South San
Francisco, CA, USA) and an HRP-conjugated secondary
antibody.
CPZ enzymatic activity assay
Homogenates of growth plate chondrocyte pellets were
assayed for carboxypeptidaseactivity using a dansyl-tagged
peptide containing a C-terminal arginine (dansyl-Phe-Ala-
Arg) as a substrate.
(12) Cleavage of the C-terminal arginine
results in a solubility change (i.e., the water-soluble dansyl-
Phe-Ala-Arg is converted into the chloroform-soluble
dansyl-Phe-Ala). Homogenates of growth plate cell pellets
were incubated with 0.2 mM of dansyl-Phe-Ala-Arg in 100
mM Tris-Cl buffer (pH 7.4) in a ﬁnal volume of 250 ml.
After 2 h at 378C, the reaction was terminated with 100 ml
of 0.5 M HCl and 1 ml of chloroform was added. After
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the chloroform phase and normalized to the total protein
content in the homogenate.
(13)
Alkaline phosphatase activity assay
Alkaline phosphatase activity was measured in growth
plate chondrocytes in pellet cultures. Pellets were homog-
enized, and alkaline phosphatase activity was determined
as previously described using p-nitrophenol phosphate
(Sigma) as a substrate.
(10) One unit of alkaline phosphatase
was deﬁned as the enzyme activity that liberated 1 mmol
p-nitrophenol per 30 min at 378C/mg of protein.
Transient transfections
TCF/LEF transcriptional activity was evaluated using
the TCF Reporter Plasmid Kit from Upstate.
(9) Chondro-
cytes were plated in monolayer culture and transfected
using Fugene 6 (Roche, Indianapolis, IN, USA) and a
TOPFlash reporter construct along with an internal control
(phRG-TK; Promega, Madison, WI, USA). Twenty-four
hours later, the transfection mixture was replaced with
original medium with or without Ad-CPZ or Wnt-4–con-
ditioned medium. After 48 h, cells were harvested and
assayed for luciferase activity using the Dual-luciferase
Reporter Assay System (Promega). The results were rep-
resented as the ﬁreﬂy luciferase relative light units (RLU)
normalized to the Renilla luciferase RLU of the same
sample.
RNA knockdown experiments were performed using
RNA interference technique. The siRNA for Wnt-4
(NM_053402) and CPZ (NM_031766) were synthesized
by Dharmacon (Lafayette, CO, USA) (siGENOME
SMARTpool siRNA reagent, M-097135-00 and L-093743-
01, respectively). siRNA against Wnt-4 or CPZ was trans-
fected with Oligofectamine (Invitrogen) into growth plate
chondrocytes cultured in monolayer according to the
method of Elbashir et al.
(14) siCONTROL from Dharma-
con was used as a negative control. Quantitative RT-PCR
was performed 36 h after transfection to conﬁrm the
knockdown of Wnt-4 and CPZ mRNA expression.
MALDI-TOF spectroscopy analysis
Analysis of the Wnt-4 C-terminal peptide was performed
on a Micromass TofSpec 2E matrix-assisted laser desorp-
tion/ionization time-of-ﬂight (MALDI-TOF) mass spec-
trometer. Freshly isolated growth plate chondrocytes were
plated in 60-mm culture dishes in DMEM/F12 supple-
mented with ITS+. The cells were infected with Ad-CPZ or
control Ad-Gal at an MOI of 100 for 48 h. Two hundred
microliters ofthe cellhomogenates was incubated with25ml
of a synthetic peptide consisting of the 16 C-terminal amino
acids of the Wnt-4 protein (VKCRQCQRLVEMHTCR) at
a concentration of 0.5 mM in 100 mM Tris-Cl buffer (pH
7.4) in a ﬁnal volume of250 ml. After 2-h incubation at378C,
the reaction was terminated with 100 mlo f0 . 5MH C l .T h e
samples were diluted 1:2 in acetonitrile, and a 1.5-ml aliquot
of the diluted sample was added to 18.5 mlo fm a t r i x( a-
cyano-4-hydroxycinnamic acid, 10 mg/ml in acetonitrile/
ethanol/water 4/4/2). The MALDI spectra were acquired in
the reﬂectron mode, using a constant laser power. Each
spectrum was generated by combining the data from ;200
laser shots.
Site-directed mutagenesis
Truncated Wnt-4 lacking the C-terminal arginine was
created using the QuickChange II Site-directed Mutagen-
esis Kit (Stratagene, La Jolla, CA, USA) according to the
manufacturer’s instructions. HA-tagged mouse Wnt4
cDNA in pUSEamp was purchased from Upstate Bio-
technology (Charlottesville, VA, USA). The primers used
to amplify wildtype Wnt-4 without the HA-tag were 59-
GCACACGTGCCGGTAATTAATTAAGATCCGG-39
and 59-CCGGATCTTAATTAATTACCGGCACGTGT
GC-39. The primers used to create truncated Wnt-4 were
59-GCACACGTGCTAATTAATTAAGATCCGGCTC-
39 and 59-GAGCCGGATCTTAATTAATTAGCACGT
GTGC-39 (underlined letters represent the mutation of the
complementary primers). To create the truncated Wnt-4
cDNA, the nucleotide coding sequence for the C-terminal
arginine in the mouse Wnt-4 cDNA (CGG) was deleted
and replaced with a premature stop codon (TAA).
To generate Wnt-4–conditioned medium, wildtype and
truncated Wnt-4 plasmids were transiently transfected into
HEK293 cells and cultured in DMEM containing 10%
FBS. Control medium was obtained from HEK293 cells
transfected with empty pcDNA3 plasmid under the same
conditions. Medium was collected 48 h after transfection.
Protein levels of Wnt-4 in the conditioned medium were
examined by immunoblotting using antibody recognizing
both wildtype and truncated Wnt-4 (Zymed) (Fig. 6A).
Wnt-4–conditioned medium or control medium was added
to the pellet cultures in a 1:5 ratio by volume of DMEM/
F12 containing ITS+.
Statistical analysis
The data are represented as mean ± SD of triplicate
samples from at least three independent experiments.
Values were assessed by one-way ANOVA with the Bon-
ferroni posthoc test and Student’s t-test at a signiﬁcance
level of p < 0.05.
RESULTS
Wnt-4 and CPZ expression co-localize in the
growth plate
Combining the LCM technique with quantitative real-
time PCR analysis allowed the mRNA expression in the
different cell populations of the growth plate to be analyzed
(Fig. 1A). Increased expression of both Wnt-4 and CPZ
mRNA was observed in the prehypertrophic and hyper-
trophic zones of the distal femoral growth plate compared
with the resting and proliferating zone (Figs. 1B and 1C).
T3 upregulates CPZ expression and increases CPZ
enzymatic activity
CPZ mRNA expression was examined by quantitative
real-time PCR analysis of total RNA extracted from resting
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mone for 1–5 days.CPZ expression was increasedas early as
day 2 in pellet cultures of growth plate cells treated with T3,
with a 16-fold increase in CPZ expression observed after 5
days of T3 treatment (Fig. 2A).
To conﬁrm that the increase in CPZ gene expression
indeed resulted in a corresponding increase in CPZ pro-
tein, anti-sera raised to the carboxyl terminus of CPZ were
used for immunoblotting of cell lysates from the growth
plate cells treated with T3 for 2–7 days. Figure 2B shows a
corresponding increase in immunoreactive CPZ with the
correct molecular weight (71 kDa) in response to T3
treatment.
Carboxypeptidase enzymatic assays using the substrate
dansyl-Phe-Ala-Arg at pH 7.4 showed increased CPZ ac-
tivity in homogenates from growth plate cells treated with
T3 for 5 days compared with homogenates from controls
without T3 treatment (Fig. 2C).
Knockdown of either Wnt-4 or CPZ expression
or inhibition of CPZ enzymatic activity interferes
with T3-induced terminal differentiation
Wnt-4 or CPZ RNA knockdown experiments were
performed using an siRNA approach. Quantitative RT-
PCR showed that transfection with anti-Wnt4 or anti-CPZ
FIG. 1. Wnt-4 and CPZ are co-expressed in
growth plate chondrocytes. (A) Photomicro-
graph of a toluidine blue–stained histologic
section of the 2-day-old rat distal femoral
growth plate, showing the regions of resting
zone (RZ), proliferating zone (PZ), pre-
hypertrophic zone (PreHZ), and hypertro-
phic zone (HZ) captured by laser capture
microdissection. (B and C) Quantitative real-
time RT-PCR analysis of expression of Wnt-4
mRNA (B) and CPZ mRNA (C) in laser
capture microdissected cells from RZ, PZ,
preHZ, and HZ of growthplate cartilage. The
expression levels were normalized to the ex-
pression in RZ cells.
FIG.2. Thyroidhormonetreatmentincreases CPZexpressionand CPZ carboxypeptidaseactivity inrat growth platechondrocytes.(A)
Quantitative real-time PCR analysis of CPZ mRNA expression in growth plate chondrocyte pellet cultures treated with T3 (100 ng/ml)
for 1–5 days. The expression of CPZ in T3-treated cells was normalized to the expression in T3-untreated cells (*p < 0.05 vs. the T3-
untreated cells). (B) Immunoblotting of CPZ protein from whole cell lysates of growth plate chondrocytes treated with or without T3
(100 ng/ml) for 2–7 days. Actin was used as an internal control. (C) CPZ carboxypeptidase activity in growth plate chondrocytes treated
with T3 (100 ng/ml) for 5 days. Cleavage of Dansyl-Phe-Ala from Dansyl-Phe-Ala-Arg was measured in the chloroform phase and
normalized to the total protein content in the homogenate (*p < 0.05 vs. the T3-untreated cells).
268 WANG ET AL.siRNA resulted in 50–80% suppression of gene expression
after 36 h of treatment at a ﬁnal concentration of 100 nM
(data not shown). Figure 3A shows that Wnt-4 mRNA
expression after 5 days of T3 treatment was reduced by
50% by the anti-Wnt4 siRNA. T3-induced CPZ mRNA
expression was reduced by 70% by knockdown with anti-
CPZ siRNA (Fig. 3C). T3-induced increases of Wnt-4 or
CPZ protein levels were also attenuated by anti-Wnt4 or
anti-CPZ siRNA, respectively (Figs. 3A and 3C).
Analysis of markers of chondrocyte terminal differenti-
ation showed that T3-induced increases in alkaline phos-
phatase enzymatic activity and Col10a1 mRNA expression
(Figs. 3B and 3D) were decreased by ;50% in the Wnt-4
or CPZ knockdown cells compared with controls.
GEMSA has been previously shown to be a potent in-
hibitor of CPZ enzymatic activity in an in vitro assay using
puriﬁed CPZ protein.
(13) Inhibition of CPZ activity by
GEMSA signiﬁcantly reduced the T3-induced increases in
alkaline phosphatase activity and Col10a1 mRNA expres-
sion by growth plate chondrocytes in a dose-dependent
manner at concentrations ranging from 0.01 to 2 mM (Figs.
3E and 3F).
CPZ binds to Wnt-4 and removes its
C-terminal arginine
For detection of binding of CPZ to Wnt-4 in growth
plate chondrocytes, cells were transfected with a Wnt-4
expression plasmid and treated with Ad-CPZ for 2 days.
FIG. 3. T3-induced increases in terminal
differentiation of growth plate chondrocytes
are suppressed byeitherknockdownofWnt-4
or CPZ mRNA expression or by inhibition of
CPZ enzymatic activity. (A) Wnt-4 mRNA
expression and Wnt-4 protein levels in
growth plate chondrocytes subjected to Wnt-
4 mRNA knockdown and treatment with T3
for 5 days (*p < 0.05 vs. the cells treated with
control siRNA and T3). (B) Alkaline phos-
phatase activity and expression of Col10a1
mRNA in growth plate chondrocytes sub-
jected to Wnt-4 knockdown and T3 treatment
for 5 days (*p < 0.05 vs. the cells treated with
control siRNA and T3). (C) CPZ mRNA
expression and CPZ protein levels in growth
plate chondrocytes subjected to CPZ mRNA
knockdown and treatment with T3 for 5 days
(*p <0.05vs. cellstreatedwith controlsiRNA
and T3). (D) Alkaline phosphatase activity
and expression of Col10a1 mRNA in growth
plate chondrocytes subjected to CPZ knock-
down and T3 treatment for 5 days (*p < 0.05
vs. cells treated with control siRNA and T3).
(E and F) Alkaline phosphatase activity (E)
and Col10a1 mRNA (F) of growth plate
chondrocytes treated for 5 days with T3 and
the carboxypeptidase inhibitor GEMSA (*p <
0.05 vs. cells treated with T3 alone).
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sates conﬁrmed the physical association of Wnt-4 with CPZ
(Fig. 4A).
The interactions between CPZ and Wnt-4 were further
analyzed using MALDI-TOF spectroscopy. Homogenates
of growth plate chondrocytes treated with Ad-CPZ were
collected and incubated with a synthetic peptide consisting
of the 16 C-terminal amino acid residues of Wnt-4 (16-aa,
VKCRQCQRLVEMHTCR, with a calculated mass of
1990 Da). Analysis of the samples by MALDI showed a
relative molecular mass of 1834 Da after incubation of 16-
aa with CPZ-containing homogenates, corresponding to
the predicted position of the 15 amino acid fragment (15-
aa, VKCRQCQRLVEMHTC) that remains after cleavage
of the C-terminal arginine by CPZ (Fig. 4B). The peak at
1834 observed in control homogenate was attributed to
endogenous CPZ in chondrocytes.
CPZ promotes Wnt signaling and terminal
differentiation of growth plate chondrocytes
Adenoviral overexpression of CPZ increased both the
cellular accumulation of b-catenin (Fig. 5A) and TCF/LEF
transcriptional activity (Fig. 5B) in growth plate chondro-
cytes. Both alkaline phosphatase activity and Col10a1
mRNA were also increased after infection with Ad-CPZ at
an MOI of 100 (Figs. 5C and 5D). These effects of CPZ
alone on chondrocyte Wnt signaling and terminal differ-
entiation were signiﬁcantly enhanced by co-addition of
Wnt-4–conditioned medium (Figs. 5A–5D).
CPZ enhances the Wnt-4 activity in growth
plate chondrocytes
To study the possible role of CPZ and Wnt-4 interaction
in the regulation of the Wnt signaling pathway, growth
plate cells were treated with Wnt-4–conditioned medium
alone or in combination with Ad-CPZ. The combined
treatment of Wnt-4–conditioned medium and CPZ ade-
novirus increased the cellular accumulation of b-catenin
and TCF/LEF transcriptional activity in growth plate cells
compared with treatment with Wnt-4 alone (Figs. 6B and
6C) and also produced signiﬁcantly greater levels of alka-
line phosphatase activity and Col10a1 mRNA expression
than Wnt-4 alone after 5 days of treatment (Figs. 6D and
6E). The increases in TCF/LEF transcriptional activity,
alkaline phosphatase activity, and Col10a1 mRNA ex-
pression induced by the combination of CPZ and Wnt-4
were signiﬁcantly greater than in control cells without CPZ
and Wnt-4 treatment.
Cleavage of the C-terminal arginine of Wnt-4
enhances Wnt-4 activity
To determine whether Wnt-4 is a potential target of CPZ
activity in the growth plate, a truncated Wnt-4 (DWnt-4)
expression vector lacking the C-terminal arginine was
constructed by site-directed mutagenesis. This change in
the cDNA sequence was conﬁrmed by DNA sequencing of
the plasmid.
Compared with full-length Wnt-4, incubation of growth
plate cells with the truncated Wnt-4 construct induced an
FIG. 4. CPZ binds to Wnt-4 and removes its C-terminal arginine
in growth plate chondrocytes. (A) Co-immunoprecipitation
and immunoblotting. Cell lysates from growth plate chondrocytes
transfected with a Wnt-4 expression plasmid and infected with Ad-
CPZ for 2 days were immunoprecipitated (IP) with CPZ anti-sera
and immunoblotted using an anti-Wnt-4 antibody. Wnt-4 and CPZ
were also detected in the input lysates (5% of the input for im-
munoprecipitation). (B) MALDI-TOF mass spectrometric analy-
sis. A syntheticpeptide consisting of the C-terminal 16 amino acids
of Wnt-4 was incubated at 378C for 2 h with control buffer or
homogenates of growth plate chondrocytes infected with or with-
out Ad-CPZ. The peak at 1834 indicates the position of the 15-aa
peptide lacking the C-terminal arginine, whereas the peak at 1990
indicates the position of the 16-aa peptide containing the C-ter-
minal arginine.
270 WANG ET AL.increased cellular accumulation of b-catenin (Fig. 6B) and
TCF/LEF transcriptional activity (Fig. 6C) and was more
potent in increasing alkaline phosphatase activity (Fig. 6D)
and Col10a1 mRNA expression (Fig. 6E) than the wildtype
Wnt-4. The effects of truncated Wnt-4 without C-terminal
arginine were comparable to the effects of the combination
of wildtype full-length Wnt4 and CPZ treatment from the
same group of cell cultures at the same time point.
FIG. 5. CPZ promotes and Wnt-4 enhances
terminal differentiation of growth plate
chondrocytes. (A) Immunoblotting of b-cat-
enin from whole cell lysates of growth plate
chondrocytes infected with Ad-CPZ (MOI of
100) for 4 days in the absence or presence of
Wnt-4–conditioned medium. Actin was used
as an internal control. (B) TCF/LEF tran-
scriptional activity (TOPFlash) of growth
plate chondrocytes infected with Ad-CPZ for
48 h in the absence or presence of Wnt-4–
conditioned medium. (C and D) Alkaline
phosphatase activity (C) and Col10a1 mRNA
expression (D) in growth plate chondrocytes
infected with Ad-CPZ for 4 days in the ab-
sence or presence of Wnt-4–conditioned me-
dium. The data are expressed as the fold
increase over the control Ad-Gal–infected
cells (*p < 0.05 vs. control cells infected with
Ad-Gal; **p < 0.05 vs. cells infected with Ad-
CPZ).
FIG. 6. Both overexpression of CPZ and removal of the Wnt-4 C-terminal arginine promote Wnt4-activated Wnt/b-catenin signaling
and terminal differentiation of growth plate chondrocytes. Growth plate cells were treated with Wnt-4–conditioned medium in the
presence or absence of infection with Ad-CPZ (MOI of 100) or treated with C-terminal arginine-truncated Wnt-4 (DWnt-4)–conditioned
medium. (A) Immunoblotting of Wnt-4 protein levels in conditioned medium from HEK293 cells transfected with wildtype or truncated
Wnt-4or emptyplasmid.(B) Immunoblottingof the cell lysates afteroverexpressionof Wnt-4, Wnt-4and CPZ, or DWnt-4for 5 days. (C)
TCF/LEF transcriptional activity in cells treated with Wnt-4, Wnt-4 and CPZ, or DWnt-4 for 48 h. (D) Alkaline phosphatase activity in
cells treated with Wnt-4, Wnt-4 and CPZ, or DWnt-4 for 5 days. (E) The cells treated with Wnt-4, Wnt-4 and CPZ, or DWnt-4 for 5 days
were analyzed for Col10a1 mRNA expression, which was normalized to the expression of Wnt-4 (including both Wnt-4 and DWnt-4) in
the same cells. The data were expressed as the fold over the control cells without CPZ, Wnt-4, or DWnt-4 treatment (*p < 0.05 vs. cells
treated with full-length Wnt-4–conditioned medium alone).
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Wnt-4 expression is upregulated by thyroid hormone
in growth plate chondrocytes
(9) and has been discovered
to act as a positive regulator of terminal differentiation
of growth plate chondrocytes during skeletal development.
In a chick model, Wnt-4 blocks the initiation of chondro-
genesis and accelerates terminal chondrocyte differentia-
tion.
(15–17) Conditional expression of Wnt-4 during chon-
drogenesis also leads to dwarﬁsm in mice through inhibition
of growth plate chondrocyte proliferation and promotion
of hypertrophy.
(18) In this study, we conﬁrmed that Wnt-4
plays a key role in the thyroid hormone–mediated termi-
nal differentiation of growth plate chondrocytes. This
study also identiﬁes CPZ as an important enzyme that
is able to remove the C-terminal arginine from Wnt-4 in
growth plate chondrocytes, and this removal not only
increases Wnt-4 activity, but also further promotes ter-
minal chondrocyte differentiation. These ﬁndings indicate
that the potent and positive thyroid hormone effect on
skeletal maturation may result in part from CPZ-mediated
activation of Wnt signaling in the growth plate. It also
suggestsamodelofthyroidhormoneaction inwhichthyroid
hormone initially upregulates the expression of both Wnt-
4 and CPZ. CPZ subsequently removes the C-terminal
arginine from Wnt-4, thereby enhancing the activity of
Wnt-4 in stimulating Wnt/b-catenin signaling and further
promoting the terminal differentiation of growth plate
chondrocytes.
Novikova et al.
(7) examined the distribution of CPZ
throughout mouse embryonic development and found
that CPZ is expressed in mouse cartilage condensations
at E17, and that, in general, CPZ expression in adult tis-
sues is much less abundant than in embryonic organs.
The expression pattern of CPZ overlaps with the expres-
sion pattern of several Wnt genes, which are also maxi-
mally expressed during mouse embryonic development
but expressed in a more restricted fashion in adult tissue.
Wnt-4 is the only known Wnt ligand that contains a pre-
dicted C-terminal arginine residue in both rat and mouse
species. In the chick, both Wnt-4 and Wnt-8c have predicted
C-terminal arginine residues, and interestingly, also are
the only two Wnts known to induce terminal differentiation
of growth plate chondrocytes.
(17) Wnt-8c, which is not ex-
pressed in mice, rats, or humans, actually has arginine resi-
dues in the last two carboxyl positions.
(19) The single
C-terminal arginine is conserved in human, mouse, rat, and
chick Wnt-4 proteins, whereas none of the other Wnts (ex-
cept Wnt-9b inthe mouse) exhibit this feature. This suggests
the possibility that the C-terminal arginine residue may be
important in the transduction of the Wnt signal that en-
hances terminal differentiation of growth plate cells.
The presence of the CRD domain within the CPZ pro-
tein and the co-localization of CPZ expression with Wnt-4
expression in the growth plate suggest that CPZ functions
as a Wnt-binding protein. During canonical Wnt signaling,
Wnt proteins serve as ligands for the Frizzled family of
transmembrane receptors and act through the b-catenin
pathway to regulate gene expression. The cysteine-rich
Wnt binding domain does not occur only in Frizzled pro-
teins but is also found in secreted Frizzled-related proteins
(sFRPs), which antagonize Wnt action by competing with
the Frizzled transmembrane receptors for Wnt binding.
Although CPZ also harbors a CRD domain, unlike the
sFRPs which inhibit Wnt signaling, CPZ binds to Wnt-4
and enhances its activity by proteolytically removing the
arginine at the C terminus. Therefore, we postulate that the
catalytic domain in CPZ, as opposed to the CRD domain,
plays the pivotal role in the modulation of Wnt function.
However, binding to Wnt-4 through the CRD may be
needed to allow the catalytic action of CPZ to occur.
We conclude from these studies that CPZ may act as a
critical linkbetweenthe thyroid hormone and Wnt signaling
pathways in the growth plate. It is possible that the car-
boxypeptidase domain of CPZ cleaves substrates other than
the Wnt-4 protein in promoting Wnt signaling and chon-
drocyte terminal differentiation. For example, in the chick
model, Wnt-8c might be another target of CPZ. Nonethe-
less, these studies identify CPZ as an enzyme capable of
regulating Wnt-4 activity in the terminal differentiation of
rat growth plate chondrocytes. These ﬁndings not only have
signiﬁcant implications for our understanding of skeletal
biology of the growth plate but also raise the possibility that
CPZ-mediated Wnt activation might be a general mecha-
nism of thyroid hormone action during development.
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